Early gene expression biomarkers sensitive to a micro volume of blood in the joint
High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis
Thrombin-induced podocyte injury is protease activated receptor (PAR)-3 and -4 dependent
Proteinuria severity is directly correlated with ex vivo and in vivo markers of thrombotic potential in an experimental model of nephrotic syndrome
Tissue factor-expressing tumor cells can bind to tissue factor pathway inhibitor under static and shear conditions in vitro
Effect of truncations on integrin β3 mimicking calpain cleavage on integrin signal transduction in platelets of β3-transgenic mice
The effect of UC-MSC homing on the immune inflammatory microenvironment and targeted improvement of prothrombotic state
Spatial dynamics of fibrin clot growth investigation: measurement of frozen plasma samples and evaluation of the assay sensitivity to the different concentration of trisodium citrate added during blood collection
The relation of inflammatory factors and immunerelated prothrombotic state in CIA rats
Inferior vena cava (IVC) branch variations in C57BL/6 mice impact thrombus size in IVC ligation model
Organ-specific tissue factor activity is significantly altered in experimental malaria
Neutralization of hemorrhage induced by direct factor Xa and thrombin inhibitors by prothrombin complex concentrates in a rat model
Equid herpes virus type-1 activates platelets through the procoagulant effects of tissue factor
Development of cell lines producing fully active recombinant vitamin K-dependent (VKD) clotting factors without vitamin K epoxide reductase (VKOR) coexpression
Establishment of anti-tetanus human immunoglobulin national standard for potency test
Platelets from premature neonates have increased platelet affinity for von Willebrand factor (VWF) under arterial shear compared to platelets from term neonates
Simultaneous measurement of thrombin generation and fibrin formation in plasma and whole blood applying continuous flow
Reversal of enoxaparin-induced anticoagulation in healthy subjects by andexanet alfa (PRT064445), an antidote for direct and indirect fXa inhibitors—a phase 2 randomized, double-blind, placebo-controlled trial
Statin use reduces incidence of adverse events in patients with atrial fibrillation: analysis in ACTIVE-W & A and AVERROES studies
Development of renal dysfunction in atrial fibrillation patients: the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) experience
Vitamin K antagonists vs. heparin for the treatment of splanchnic vein thrombosis in the isth registry: results of 12-month follow-up and a propensity score analysis
Safe implementation of the new oral anticoagulants (NOACs) requires patient monitoring
Defining time in therapeutic range for clinicians: frequency of dose changes is a good surrogate marker for identifying patients with suboptimal anticoagulation with warfarin
What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?
Presence of direct factor Xa inhibitors leads to a protracted thrombin generation peak
Clinical outcome of major bleeding in patients on oral anticoagulant treatment: results from the CLIMBING Study
The experiences of consultations on oral anticoagulation for AF: the importance of qualitative research in cardiovascular sciences
Vitamin K antagonist therapy induces high plasma levels of factor VIII and fibrinogen and reduces thickness of fibrin fibers
Interest of thrombin time in the periprocedural management for patients on dabigatran etexilate
Impact of thrombophilia testing on diagnosis and treatment of patients with neurologic disorders: a single-center experience
Major orthopedic surgery: is the risk of major bleeding higher in elderly patients?
Effect of eculizumab therapy on the coagulation status of patients with paroxysmal nocturnal hemoglobinuria
Oral anticoagulation treatment and PT INR response in our department; comparison between 2009 and 2014
Streptokinase and low molecular weight heparin affect platelet aggregation in Ukrainian patients with atherothrombotic and cardioembolic ischemic stroke
Coumadin-induced skin necrosis: case presentation
Effects of impaired renal function on levels and performance of D-dimer in patients with suspected pulmonary embolism
Efficacy and safety outcomes of treatment of acute venous thromboembolism: a systematic review and network meta-analysis
Effectiveness, safety and management of novel direct oral anticoagulants in daily care - updated results of the prospective Dresden noac registry (NCT01588119)
Reasons for not-switching from VKA to NOAC and persistence on VKA - a VKA subgroup analysis of the prospective Dresden NOAC registry (NCT01588119)
Centrally adjudicated cause of death during anticoagulant treatment - results of the prospective Dresden NOAC registry (NCT01588119)
How should we measure the reversal of direct factor XA or thrombin inhibitors by prothrombin complex concentrate?
No effect of platelet supplementation to reverse the P2Y12 inhibitor ticagrelor: an in vitro study
The effect of rifampin on the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban in healthy subjects
Healthcare cost of recurrent venous thromboembolism and bleeding events among patients with acute venous thromboembolism
Time course of recurrent venous thromboembolic and major bleeding events during anticoagulant therapy with apixaban or enoxaparin/warfarin: analysis of the amplify data using landmark method
The prothrombinase induced clotting time test (PICT®), a robust alternative to aptt in the management of ufh therapy
Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among patients with venous thromboembolism based on clinical trial results
Incremental healthcare burden of bleeding among patients with venous thromboembolism in the US
Sensitivity of prothrombin time to the presence of rivaroxaban varies substantially between reagents and subjects
Appropriateness of management of target specific anticoagulants in an inner-city population
Spinart trial 3-year results: improved quality of life in adults using prophylaxis with Bayer's sucrose-formulated recombinant factor VIII
The effects of apixaban on routine coagulation tests including prothrombin time and activated partial thromboplastin time
Determinants of anticoagulation adherence using Morisky medication adherence scale
Anticoagulation reversal and event study collaborative (ARES) - initial results
Measuring dabigatran with the dilute Russell viper venom confirm assay in an anticoagulation clinic population
Measuring new oral anticoagulants in thrombin generation on Ceveron® alpha
Characterization of the population pharmacokinetics of Bayer's rFVIII-FS in phase I/II shows that clearance is affected by lean body weight and von Willebrand factor
Switching from dabigatran or rivaroxaban to edoxaban: a biomarker assessment in healthy subjects
Inflammatory and thrombotic response to arthroplasty in patients undergoing total hip/knee arthroplasty
Dilute FIIX prothrombin time as a single test to assess the anticoagulant effect of warfarin, dabigatran and rivaroxaban
Assessment of rivaroxaban and edoxaban on automated analyzers using a liquid anti-XA assay for apixaban
Mean normal prothrombin time determination for use in the pt INR calculation: methods of verification and picking the ‘right’ number
Upper extremity deep vein thrombosis: a longitudinal follow-up
Tissue factor pathway inhibitor (TFPI) in patients with sepsis receiving prophylactic enoxaparin
The start-register (survey on anticoagulated patients register): baseline data of included patients, with focus on those treated for non-valvular atrial fibrillation
Impact of local prothrombin time reagent ISI assignment on proficiency testing results: a multi-instrument and laboratory experience
Comparison of local and systemic inflammatory, fibrinolytic and hemostatic parameters in patients with varicose veins
Isolated A2 domain of von Willebrand factor that binds to fibrin inhibits microvascular thrombosis and reduces mortality of mice with endotoxemia-induced disseminated intravascular coagulation
Disseminated intravascular coagulation scoring system in cardiac surgery patients with postoperative severe sepsis
Tracking progression of LPS induced disseminated intravascular coagulopathy using a native whole blood thrombin generation assay
Utility of soluble fibrin monomer complex (SFMC) in the laboratory evaluation of disseminated intravascular coagulation (DIC)
Up-regulation of a novel inflammatory mediator, endocan, in patients with sepsis associated coagulopathy
Immunity-coagulation interface in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis
The intensity of the intravascular microcoagulation at the patients with atherothrombosis and thrombophilia
Evidence that extravascular human factor IX influences pharmacokinetics in hemophilic B dogs
Comparison of efficacy and safety between aryogen recombinant activated factor VII (Aryoseven™) and Novoseven® in the main on-label (approved) indications of recombinant activated factor VII in Iran
Impairment of plasma clotting by crystalloid solutions is related to ionic strength and presence of chloride ions
Assessment of protein aggregates and sub-visible particles in different recombinant FVIII preparations
The laboratory measurement of a glycopegylated recombinant FVIII, N8-GP: a two centre study
Clinician reported ease of use for a novel fibrin sealant patch for hemostasis: results from three randomized controlled trials
Assessment of in vivo administered recombinant activated factor VII by thrombelastography using two different coagulation activators
Safety and efficacy profile of a biosimilar recombinant factor VIIA in patients with factor VII deficiency
The laboratory measurement of a glycopegylated recombinant FIX, N9-GP: a two centre study
Non-pathogenic antibodies against human recombinant proteins - what is their relevance?
The procoagulant activity on nephrotic syndrome induced by adriamycin in rats
In vivo selection of genetically manipulated platelets corrects murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection for transduction
Revascularization strategies and in-hospital outcomes in acute coronary syndromes (ACS) complicated by hemophilia A (HA) or B (HB)
Risk of inhibitor development in previously treated patients with positive inhibitor history or low titer of inhibitor at baseline: results of a survey of hemophilia experts
Investigation of the biological fate of 40 kDa PEG following single dose administration of glycopeglylated factor IX (N9-GP) to fix knockout mice
APTT reagents do not interfere with the heat/cold modified FIX Bethesda assay for detection of inhibitors in samples with pegylated FIX
Post translational modifications and pharmacokinetics of recombinant factor IX (RFIX) derived from HEK293 and CHO, and plasma-derived (PD) FIX
Highly discrepant inhibitor titres in the Bethesda assay as a function of FVIII source: plasma vs. isolated FVIII
Effect of APTT reagents on factor XI activation and thrombin generation in one-stage clotting assays and its correlation with factor IX product activity determination
Identification of binding partners for b domain of FVIII by yeast two hybrid screen
Sensitivity and variability of the thrombin generation assay using recombinant factor VIII (turoctocog alfa) and factor IX, and their glycopegylated derivatives with either tissue factor or factor XIA to trigger the reaction
Comparison between spiked and postinfusion samples of N9-GP evaluated by ELISA, one-stage clot assay, and chromogenic assay
Feasibility of high through-put rapid turnaround mutational analysis for patients with hemophilia using dried blood spots
Latest results from the PUP-GCP clinical trial: a low inhibitor rate in previously untreated patients with severe hemophilia A treated with octanate
In vitro characterization of the first plasma-derived factor V concentrate in development
Comparison of RIXUBIS with another recombinant factor IX product for function, safety, and efficacy with focus on factor IXA content
Investigation of hemostasis and fibrinolysis in FVIII-sensitive thromboelastometry
A generic version of recombinant factor VIIA is comparable to the branded product (NovoSeven)
Comparison of RIXUBIS with another recombinant FIX product for behavior in chromogenic and one-stage clotting assays using different APTT reagents
Molecular profile and prothrombin complex activation studies on a branded factor VIIA and a biosimilar product
Variability in the thromboplastin-mediated thrombin generation in commercially available prothrombin complex concentrates
Observational Immune Tolerance Induction Research Program (ObsITI)—a multifaceted approach to explore immune tolerance induction
Impact of corn trypsin inhibitor (CTI) on the thrombin generation assay of plasma samples collected from a phase 3 multicenter clinical trial in severe hemophilia A subjects
Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalization with external reference plasma
Personalizing prophylactic treatment in adult patients with severe hemophilia A
Anti-inhibitor complex concentrate prophylaxis in hemophiliacs with inhibitors
The coherence of menorrhagia and rare bleeding disorders
Acute deep cerebral venous thrombosis associated with cerebral hemorrhage in an elderly female: a case report
Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment
Molecular genetic analysis of glanzmann thrombasthenia in Pakistani cohort reveals novel mutations
Impact of ADAMT13 deficiency on the pathogenesis and treatment of thrombotic thrombocytopenic purpura (TTP): a systematic review
The validity of algorithms for identifying suspected and confirmed heparin-induced thrombocytopenia
Psychiatric disorder as expression of beta-thalassemia intermedia
Characterization and development of factor XIIA inhibitors for assaying tissue factor-triggered coagulation
A retrospective review of rare coagulation factor deficiencies in a tertiary hospital (Singapore)
Evaluation of assays for factor XIa to reduce the thrombotic risk of immunoglobulins
Identification of sequence variations in fibrinogen genes causing hemorrhagic or thrombotic diathesis
Congenital fibrinogen deficiency in Pakistan and identification of five novel mutations
Identification of novel mutations in fibrinogen gene alpha (FGA) and frequency of mutations in Pakistani population
Measuring plasma fibrinogen levels below 40 mg dL-1 using the STA®-Liquid FIB reagent
Clinically relevant discrepancies between fibrinogen analysis methods in patients undergoing thrombolytic therapy for acute iliofemoral deep venous thrombosis
Differential effect of dabigatran, rivaroxiban and apixaban on thrombomodulin mediated activation of protein C and thrombin activated fibrinolysis inhibitor (TAFI) may impact their safety and efficacy profiles
The Netherlands purification and characterization of novel enzymes with antiplatelet and anticoagulant activities from snake venom
New approach for D-dimer antibody selection
Introduction of a point of care D-dimer EQA program to include assessment of testing and postanalytical interpretation of results
MST-188 increases rates of fibrin assembly and subsequent urokinase/TPA-mediated lysis in vitro
Factor VII-derived EGFP-EGF1 protein mediate drug delivery system to TF highly expressing tumors
Thrombin-activatable fibrinolysis inhibitor gene polymorphism G-438A is associated with venous thromboembolism in cancer patients: a case-controlled study
Study of snake venom-derived antiplatelet agents
Chemotherapy-associated thrombocytopenia in breast cancer patients: a retrospective hospital-based cohort study
Platelet-microparticles (PMP) in essential thrombocythemia (ET): characterization of procoagulant and proangiogenic activities
Procoagulant properties of prostate cancer cell lines and the effect of androgen deprivation
Inferior vena cava filter usage, complications, and retrieval rate in cancer patients
Time in therapeutic range in subjects with cancer associated thrombosis
Hospital resource use and cost reduction with the use of advanced topical absorbable hemostats in surgical procedures
Duration of anticoagulation treatment for catheterrelated thrombosis in hematologic malignancy
Solid phase assays in antiphospholipid syndrome (APS): variation between results amongst UK Neqas (blood coagulation) participants
‘Weak’ effects showed similar chances of being confirmed as positive lupus anticoagulant (LA) as those with strong effects on DRVVT
Activated protein C resistance detected by the calibrated automated thrombogram as the most prevalent prothrombotic factor in patients with early manifestations of venous thromboembolism
Abstract withdrawn.
Abstract withdrawn.
Differences in sensitivity of two automated panels for anticardiolipin and anti-beta2glycoprotein I antibodies in the laboratory diagnosis of antiphospholipid syndrome due to the exposure of the domain I epitope of beta2glycoprotein I on the solid phase
Venography (VE) in children with clinical assessment of post-thrombotic syndrome (PTS) following upper venous system thrombotic event (UVSTE)
Development of a new risk model for hospital-associated venous thromboembolism (HA-VTE) in the pediatric intensive care unit (PICU): findings from a large single-institutional case-control study
Item reduction analysis of the self-PBQ (self-administered pediatric bleeding questionnaire): healthy children and children previously diagnosed with type 1 von Willebrand disease (VWD)
Idiopathic thrombosis in teenagers: the role of thrombophilia
Abstract withdrawn.
FV deficiency patients: no correlation of phenotype with factor activity and report of three new mutations in Egyptian children
Acquired FVII deficiency and glomerulopathy in Egyptian children: a report of five cases: an association and/or an immune triggered phenomenon
Effect of 22Q11.2 deletion on bleeding risk following cardiac surgery in children with congenital heart disease
Dalteparin treatment for acute pediatric venous thromboembolism: a multicenter dose-finding, safety, and efficacy study
Height and age have more impact on anti-vitamin K antagonist dose requirement than VKORC1 genotype in children/pediatric patients
Utility of thrombophilia screening in children awaiting kidney transplantation
Risk factors for hospital-associated venous thromboembolism in the neonatal intensive care unit
Site, recurrences and outcomes of deep vein thrombosis in neonates and children
Whole blood vs. reconstituted whole blood for cardiopoulmonary bypass surgery in infants
Use of warfarin oral suspension for antithrombotic therapy and prevention of thrombosis in infants and children
Corn trypsin inhibitor non-loop regions are required for the specific inhibition of factor XIIa
Measurement of plasma and platelet tissue factor pathway inhibitor (TFPI) in blood donors
Unfractionated and low molecular weight heparins, but not fondaparinux, block inhibition of prothrombinase by TFPI-alpha
Risk factors of thrombosis in an African population
Protein Z intron FG79A polymorphisms are not associated with hyperlipidemia
A new report of FVII-inhibitor in a patient suffering from severe congenital FVII deficiency
Major bleeding events with dabigatran versus warfarin in patients with acute venous thromboembolism: a pooled analysis of RE-COVER and RE-COVER II
Timing of corn trypsin inhibitor to platelet poor plasma alters thrombin generation
Interim results from the prospective observational study on Novoseven® room temperature stable (VII25) in patients with hemophilia A or B
Characterization of a high potency heparin prepared from porcine intestinal brine
Technoclot® protein s - a new simplified assay for the determination of proteins activity
Pilot study of the safety of rivaroxaban for VTE prophylaxis in non-orthopedic surgical patients
Establishment of method for determining heparin content of human antithrombin concentrate
Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients
The effects of different B-cell activating factor receptors on lymphocyte function and secretion of cytokines in immune thrombocytopenia
Standardization of the NOD SCID mouse model for the assessment of antibody-mediated thrombocytopenia
P-selectin based functional platelet flow cytometry assay for heparin-induced thrombocytopenia (HIT): platelet donor variability and laboratory selection criteria for identifying adequate donors
Regulation of platelet and neutrophil interaction in the formation of DNA extracellular traps
Variable impact of normal IgG subclasses on heparindependent platelet aggregation induced by a HIT monoclonal antibody according to FcγRIIa H131R polymorphism
Rapid detection of IgG, IgA, IgM antibodies associated with heparin-induced thrombocytopenia (HIT)
Platelet-activating HIT antibodies bind preferentially to PF4 treated platelets in the absence of heparin: implications for HIT pathogenesis
Rationale for the use of newer oral anticoagulants in the long term management of heparin induced thrombocytopenia
Evidence that clopidogrel metabolites can trigger drug-induced immune thrombocytopenia (DITP)
Serotonin release assay and flow cytometric assay in the diagnosis of hit based on experts' opinion
Morphological distinction unravels mechanisms of platelet biogenesis from bone marrow megakaryocytes
Phosphorylation of CLEC-2 by Src-family kinases is essential for anti-CLEC-2 antibody-induced receptor internalization
Combined deficiency of platelet alpha and dense granule release abrogates platelet aggregation and adhesion but has no effect on vascular integrity upon inflammation
An essential role of the inhibitory Fc gamma receptor IIb in antibody-induced glycoprotein VI ectodomain shedding in vivo
Thrombus development processes dependent on endothelial injuries: visualized by in vivo two-photon imaging
PSI domain of β3 integrin contains endogenous thiol isomerase function that can be inhibited by a PDI inhibitor bacitracin and anti-PSI monoclonal antibodies
Arginase II KO reduces platelet aggregation while sparing coagulation in aged mice
Escitalopram modifies platelet cytoskeletal assembly and has a direct inhibitory effect on thrombin-induced activation
Elevated immature platelet fraction (IPF) is useful for identifying MYH9 related disorders: a report of two cases
Comparison of fish oil and corn oil on the thrombin generation of platelet-rich plasma as measured by the calibrated automated thrombogram
Evaluation of platelets surface morphology and their local elastic properties in patients with implanted heart ventricle in the early and late postoperative period by AFM
NOD2 receptor is expressed in platelets and enhances platelet activation and thrombosis
Paired immunoglobin-like receptor b regulates platelet activation
Effects of garlic (Allium sativum) on some hematological parameters using New Zealand White rabbits
Identification of the mechanosensory domain in the platelet mechanosensor GPIb-IX complex
Macrothrombocytopenia of cases with TUBB1 mutations identified in the BRIDGE cohort
In vitro effect of procoagulant and antifibrinolytic agents on blood clot quality and stability in a model of severe thrombocytopenia
Evaluation of light transmission aggregometry (LTA) procedures and variations between laboratories in the Netherlands
Therapeutic platelet-rich plasma: characterization of platelet activation and procoagulant markers, growth factor release, and cell proliferation following pulse electric field stimulation
Systematic comparative analysis of bleeding phenotype in PT-VWD and type 2B VWD using an electronic bleeding questionnaire
Development of a laboratory model of thrombocytopenia in human whole blood
Validation of two flow cytometric methods to measure platelet surface glycoprotein proteins
Analyzing platelet thrombus formation under arterial blood flow conditions
Rapid platelet concentrate delivery by pneumatic tube system and pressured transfusion is a feasible option
Role of intracellular reactive oxygen species generation in platelet shape change
D-dimer for the diagnosis of symptomatic upper extremity deep vein thrombosis
Hypoxia induces a prothrombotic state: results from the ‘red meets white’ study
The impact of blood transfusions and the age of transfused red blood cells on long-term prognosis after transcatheter aortic valve implantation (TAVI)
Neutrophil extracellular trap formation (NETs) in diabetes: correlation with inflammatory markers
Poor response to thienopyridines and thrombotic recurrent events in patients with ischemic heart disease
Can a multidisciplinary cardiac surgery blood conservation program succeed? A single center, 6 year, 687 patient retrospective blood/blood product utilization review
A novel flow chamber system for modeling human venous thrombosis
Thrombin generation is a predictor of stroke in patients with non valvular atrial fibrillation
Observation of clot formation and lysis in conjunction with the thrombin generation assay
A large-scale comparison study of plasma fibrinogen by clauss and prothrombin time derived methods: an attempt to define critically low value of prothrombin time derived fibrinogen for bleeding patients when clauss fibrinogen is not readily available
The frequencies of thrombophilic alleles known from GWAS studies in healthy population and in group of patients with venous thromboembolism (VTE) in Czech Republic
Detection of a high rFVIIa binding subpopulation and of donor variation in the interaction of activated recombinant factor VII (rFVIIa) with human platelets by flow cytometry
Thrombin generation and blood coagulation activation in patients with a transient ischemic attacks
Quantifying the impact of diet-induced atherosclerotic plaque erosions on vessel hypercoagulability with semipermeable nanoparticle beacons
Anti-thrombin nanoparticles preserve renal function after acute ischemic injury
Cyclosporine a prevents replicative senescence-related endothelial dysfunction, pro-thrombotic and pro-coagulant responses and mp shedding in primary coronary artery endothelial cells
Microparticles released by replicative senescence in primary endothelial cells promote premature senescence associated with an impaired no formation and oxidative stress
Utilization of elastic compression stockings (ECS) following first episode of deep venous thrombosis (DVT): 15 year experience at a single veterans affairs medical center (VAMC)
Altered endothelium-dependent relaxation induced by erythrocyte membrane from subjects with different hemoglobin genotypes in isolated rabbit carotid arteries
Effect of histones on angiogenic responses of progenitor and mature endothelial cells
Frequency of post thrombotic syndrome (PTS) in patients with proximal deep venous thrombosis - a prospective observational study from a tertiary care hospital in North India
miR-503 modulation of NOS3 signaling via RICTOR
Circulating endothelial cells and progenitors as prognosis factors during auto-immune thrombotic thrombocytopenic purpura: results of a prospective multicenter french study
Retrospective database analysis of the prevalence of cardiovascular comorbidities in a US patient population with hemophilia a: confirmation of findings
Analysis of tissue factor pathway inhibitor isoforms on macro- and microvascular endothelial cells
Microparticles inhibit angiogenic activities of microvascular endothelial cells through a CD36 dependent signaling pathway involving reactive oxygen species
Enhanced presence endothelial dysfunction biomarkers in major depression disease and progressive down-regulation during antidepressant treatment
Microparticle levels in patients undergoing coronary revascularization surgery
Protective effects of connexins in atherosclerotic plaques in patients with carotid artery stenosis
Misfolding of the von Willebrand factor A1 domain in Type 2 von Willebrand disease
Allosteric activation of ADAMTS13 involves conformational changes induced by its substrate von Willebrand factor
Phenotype assignment of Type 2 von Willebrand disease (VWD) variants by a single ELISA-based assay of von Willebrand factor (VWF) functions
Patient-derived blood outgrowth endothelial cells from a Type 2b von Willebrand disease patient exhibit increased angiogenesis
Association between von Willebrand factor and factor VIII levels and their changes during the aging process
Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations
Increased active von Willebrand factor among patients with inflammatory bowel disease
Molecular characteristics and recombinant protein expression of type 2 and type 3 von Willebrand disease: studies of a Chinese cohort of 25 patients
Effect of factor von Willebrand on fibrin structure and lysis
Genotype characteristics of von Willebrand disease type III in Pakistani patients
Identification of a novel polymorphism in P.N258 of the GP1BA gene
Contribution of defective von Willebrand factor (VWF) multimerization, regulated storage, and secretion to type 1C von Willebrand disease (VWD)
Diagnosis of von Willebrand disease using a comprehensive panel of assays including gene analysis by next generation sequencing
Overlap of collagen 4 and platelet binding sites in VWF A1 domain
Evaluation of six commercial von Willebrand factor collagen binding assay kits
Update on bleeding scores in the Zimmerman program: comparison of ISTH BAT, PBQ, and MCMDM-1VWD scoring systems
Improved diagnosis of VWD in affected family members using the isth bleeding score
Classification of patients with von Willebrand disease after systematic genotypic analysis
Effect of recombinant von Willebrand factor and fractions thereof on the procoagulant activity of factor VIII
In vitro characterisation of missense mutations located in the von Willebrand factor (VWF) D1 domain associated with quantitative VWF deficiency
Performance of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor (VWF) activity assay on samples from patients receiving DDAVP or VWF concentrates
New insights into type 3 von Willebrand disease: the 3Winters-Ips project update
Determination of the VWF activity with the ristocetin independent gain of function glycoprotein 1b innovance von Willebrand activity assay
Fully automated chemiluminescent assay for the detection of von Willebrand factor collagen binding (VWF: CB)
Secondary prophylaxis in von Willebrand disease with highly purified VWF/FVIII concentrates: interim results of the PRO.WILL study
Acquired von Willebrand disease syndrome associated with Klebsiella pneumoniae infection
Surgical experience in patients with von Willebrand disease: one center report
Association between newborn birth weight and maternal venous thromboembolism in the postpartum period: a population-based case-control study
Pregnancy complications in acquired thrombotic thrombocytopenic purpura
The association between bilateral salpingo-oophorectomy and incident venous thrombosis among postmenopausal women with hysterectomy
Clinical utility of antithrombotic prophylaxis in IVF/ICSI
Mode of delivery and cranial bleeding in newborns with haemophilia, a systematic review of the literature
Association of factor V Leiden G1691A and prothrombin gene G20210A mutation with adverse pregnancy outcomes
Obstetric patients in the intensive care unit (ICU): hematologic aspects
Effects of serum adiponectin levels on platelet disaggregation in pregnant women with gestational diabetes mellitus and type 1 diabetes mellitus
Outcomes of 339 pregnancies in 181 women suffering from 13 different forms of inherited thrombocytopenia enrolled in a retrospective and multicentric study (on behalf of EHA-SWG on thrombocytopenias and platelet function disorders)
Incidence of thrombophilia testing in pregnancies complicated by current or prior thromboembolism
Descriptive analysis of pregnant women with recurrent fetal death and thrombophilia
Use of human phenome ontology (HPO) is an effective approach to cluster 519 cases of inherited bleeding and platelet disorders enrolled by 12 referral centres in an exome sequencing study
Thrombophilia testing among patients with venous thromboembolism
Identification of coding variants in susceptibility genes through genome-wide association and next generation sequencing implicated in pediatric venous thrombosis
The prevalence of gene polymorfisms of thrombocytes in patients with evidential venous thromboembolism (VTE)
The EAHAD coagulation factor variant databases